RHYTHM PHARMACEUTICALS, INC. (RYTM) Insider Trading

Name: RHYTHM PHARMACEUTICALS, INC. (RYTM) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 14, 2026): Meeker David P (President and CEO): Exercise/Conversion of 50,000 shares, $302.5K.

Get alerted when insiders trade RYTM

Email address

Loading company data...

Loading company details...